India to Indonesia: Dapsone Export Trade Route
India has recorded 1 verified shipments of Dapsone exported to Indonesia, representing a combined trade value of $36.5K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $36.5K USD. The leading Indian exporter is GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, which accounts for 100% of total export value with 1 shipments worth $36.5K USD. On the buying side, PT. GLAXO WELLCOME INDONESIA is the largest importer in Indonesia with $36.5K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Indonesia Dapsone corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $36.5K USD. The route is dominated by GLAXOSMITHKLINE PHARMACEUTICALS LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's dapsone manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $36.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with dapsone's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 25.6%, placing it at rank #6 among India's top dapsone export destinations globally.
On the import side, key buyers of Indian dapsone in Indonesia include PT. GLAXO WELLCOME INDONESIA. PT. GLAXO WELLCOME INDONESIA is the single largest importer with 1 shipments valued at $36.5K USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSTARTRACK TERMINAL ICD
Market Position
- Global rank#6
- Annual growth+25.6%
- Demand growth+21.6%
- Regulatory ease86/100
Top 10 Indian Dapsone Exporters to Indonesia
Showing top 10 of 1 Indian suppliers exporting Dapsone to Indonesia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Avg $36.5K per shipment | 1 | $36.5K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting dapsone to Indonesia, ranked by total trade value. The listed exporters are: GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED is the dominant supplier with 1 shipments worth $36.5K USD, giving it a 100% market share.
Top 10 Dapsone Importers in Indonesia
Showing top 10 of 1 known buyers in Indonesia receiving Dapsone shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dapsone in Indonesia include PT. GLAXO WELLCOME INDONESIA. The largest importer is PT. GLAXO WELLCOME INDONESIA, accounting for $36.5K USD across 1 shipments — representing 100% of all dapsone imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PT. GLAXO WELLCOME INDONESIA | 1 | $36.5K | 100.0% |
Top 10 Dapsone Formulations Imported by Indonesia
Showing top 10 of 1 product formulations shipped on the India to Indonesia Dapsone route, ranked by trade value
Indonesia imports a wide range of dapsone formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DAPSONE TABLETS 100MG (BATCH NO. F67H) — accounts for $36.5K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DAPSONE TABLETS 100MG (BATCH NO. F67H) | 1 | $36.5K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
STARTRACK TERMINAL ICD handles the highest volume with 1 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's dapsone exports to Indonesia are driven primarily by a handful of large-scale manufacturers. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Indonesia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAXOSMITHKLINE PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $36.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, PT. GLAXO WELLCOME INDONESIA is the largest importer with 1 shipments worth $36.5K USD — representing 100% of all dapsone imports from India on this route.
Route Statistics
- Trade Volume
- $36.5K
- Avg. Shipment
- $36.5K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~29 days
- Annual Growth
- +25.6%
Other Dapsone Routes
Unlock the Full India to Indonesia Dapsone Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — India to Indonesia Dapsone Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dapsone to Indonesia?
The leading Indian exporters of Dapsone to Indonesia are GLAXOSMITHKLINE PHARMACEUTICALS LIMITED. GLAXOSMITHKLINE PHARMACEUTICALS LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Dapsone exports from India to Indonesia?
India exports Dapsone to Indonesia worth approximately $36.5K USD across 1 recorded shipments. The average value per shipment is $36.5K USD.
Q Which ports does India use to ship Dapsone to Indonesia?
The most active port of origin is STARTRACK TERMINAL ICD with 1 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Indonesia for Dapsone?
The average transit time for Dapsone shipments from India to Indonesia is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Indonesia Dapsone trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.6% with demand growth tracking at 21.6%. The route is ranked #6 among India's top Dapsone export destinations globally.
Q How many suppliers are active on the India to Indonesia Dapsone route?
There are currently 1 active Indian suppliers exporting Dapsone to Indonesia. The market is moderately concentrated with GLAXOSMITHKLINE PHARMACEUTICALS LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Dapsone from India in Indonesia?
The leading importers of Indian Dapsone in Indonesia include PT. GLAXO WELLCOME INDONESIA. PT. GLAXO WELLCOME INDONESIA is the largest buyer with 1 shipments worth $36.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Indonesia export trade corridor identified from Indian Customs (DGFT) records for Dapsone.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Indonesia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists